NHI as reported
National Health Investors, Inc. reported $401M of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed.
$401M
Revenue, trailing twelve months · to Q1 2026 · +17% against the twelve months before
- Net Income
- $148M
Net Income · +4.9% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- −$105M
Free Cash Flow · +180% year on year · trailing twelve months to Q1 2026
- Op Margin
- 35%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $401M | +17% | Q1 2026 |
| Net Income | $148M | +4.9% | Q1 2026 |
| EPS | $3.10 | −1.9% | Q1 2026 |
| Op Margin | 35% | n/a | Q1 2026 |
| Net Margin | 37% | n/a | Q1 2026 |
| ROE | 9.7% | n/a | Q1 2026 |
| ROA | 5.2% | n/a | Q1 2026 |
| ROIC | 4.0% | n/a | Q1 2026 |
| Free Cash Flow | −$105M | +180% | Q1 2026 |
| P/E | 23.7 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
National Health Investors, Inc. (NHI) - Revenue & ProfitRevenue & ProfitNational Health Investors, Inc. (NHI)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
REIT - Healthcare Facilities
Ranks #1 of 10 by Smart Score